Funds holding “ABT”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
19 positions across 19 funds, 2 distinct securities (bonds, share classes and derivatives of the same issuer are listed separately). Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| THQ abrdn Healthcare Opportunities Fund Healthcare | Abbott Laboratories | 002824100 | EC | 3.74% | $39.4M | Jun 30, 2026 | full (109 positions) |
| THW abrdn World Healthcare Fund Healthcare | Abbott Laboratories | 002824100 | EC | 2.40% | $16.5M | Jun 30, 2026 | full (131 positions) |
| BME BlackRock Health Sciences Trust Healthcare | Abbott Laboratories | 002824100 | EC | 1.89% | $10.8M | Jun 30, 2026 | full (152 positions) |
| HQH abrdn Healthcare Investors Healthcare | Abbott Laboratories | 002824100 | EC | 1.82% | $24.9M | Jun 30, 2026 | full (154 positions) |
| EXG Eaton Vance Tax-Managed Global Diversified Equity Income Fund Global Equity | Abbott Laboratories | 002824100 | EC | 1.01% | $32.8M | Jul 31, 2026 | full (98 positions) |
| EVT Eaton Vance Tax-Advantaged Dividend Income Fund U.S. Equity | Abbott Laboratories | 002824100 | EC | 0.98% | $30.4M | Jul 31, 2026 | full (155 positions) |
| ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund Global Equity | Abbott Laboratories | 002824100 | EC | 0.80% | $21.6M | Jul 31, 2026 | full (180 positions) |
| ETO Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund Global Equity | Abbott Laboratories | 002824100 | EC | 0.73% | $5.5M | Jul 31, 2026 | full (180 positions) |
| GRX Gabelli Healthcare & WellnessRx Trust Healthcare | ABBOTT LABORATORIES | 002824100 | EC | 0.68% | $1.6M | Jun 30, 2026 | full (195 positions) |
| NIE Virtus Equity & Convertible Income Fund Convertible Securities | ABBOTT LABORATORIES | 002824100 | EC | 0.66% | $5.2M | Jul 31, 2026 | full (164 positions) |
| ETB Eaton Vance Tax-Managed Buy-Write Income Fund Covered Call / Option Income | Abbott Laboratories | 002824100 | EC | 0.60% | $3M | Jun 30, 2026 | full (133 positions) |
| BMEZ BlackRock Health Sciences Term Trust Healthcare | Abbott Laboratories | 002824100 | EC | 0.58% | $6.3M | Jun 30, 2026 | full (170 positions) |
| ETW Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund Covered Call / Option Income | Abbott Laboratories | 002824100 | EC | 0.34% | $3.9M | Jun 30, 2026 | full (258 positions) |
| SPXX Nuveen S&P 500 Dynamic Overwrite Fund Covered Call / Option Income | Abbott Laboratories | 002824100 | EC | 0.31% | $9.1M | Jun 30, 2026 | full (556 positions) |
| ACV Virtus Diversified Income & Convertible Fund Convertible Securities | ABBOTT LABORATORIES | 002824100 | EC | 0.26% | $983K | Jul 31, 2026 | full (281 positions) |
| JHS John Hancock Income Securities Trust Taxable Bonds | Abbott Laboratories | 002824BT6 | DBT | 0.25% | $580K | Jul 31, 2026 | full (931 positions) |
| QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Covered Call / Option Income | Abbott Laboratories | 002824100 | EC | 0.15% | $2.4M | Jun 30, 2026 | full (228 positions) |
| GDV Gabelli Dividend & Income Trust U.S. Equity | ABBOTT LABORATORIES | 002824100 | EC | 0.06% | $2M | Jun 30, 2026 | full (729 positions) |
| GOF Guggenheim Strategic Opportunities Fund Multi-Asset | ABBOTT LABORATORIES | 002824100 | EC | 0.00% | $14.1K | May 29, 2026 | full (1,841 positions) |
Matching position names
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.